国药一致：公司医药分销板块对资金需求较大

Group 1 - The core viewpoint of the article is that the company, Guoyao Yici, has acknowledged a significant funding requirement in its pharmaceutical distribution segment, which has led to an increase in accounts receivable due to external environmental impacts [1] - The company's goodwill is primarily associated with its pharmaceutical retail segment, and it conducts annual impairment tests on asset groups that include goodwill, in accordance with accounting standards and company policies [1] - The results of the impairment tests determine whether the company needs to recognize any impairment losses, thereby accurately reflecting the value of goodwill assets [1]